C12Y 204/0109
N-acetyllactosamine synthase
Official title: N-Acetyllactosamine synthase (2.4.1.90)
C12Y204/0109 (N-acetyllactosamine synthase) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 10
- Assignees
- 8
- Inventors
- 25
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 3 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of expression and/or function7 Oct 2025US 12,435,337 B2E-Therapeutics PLC
- In vivo synthesis of sialylated compounds5 Aug 2025US 12,378,589 B2Inbiose N.V.
- Fermentative production of oligosaccharides by total fermentation utilizing a mixed feedstock24 Jun 2025US 12,338,473 B2Chr. Hansen A/S
- Fermentative production of oligosaccharides by total fermentation utilizing a mixed feedstock1 Aug 2023US 11,713,475 B2Chr. Hansen HMO GmbH
- In vivo synthesis of sialylated compounds27 Dec 2022US 11,535,878 B2Inbiose N.V.
- Vivo synthesis of sialylated compounds14 May 2026US 2026/0132407 A1Inbiose N.V.
- Inhibitors of expression and/or function2 Oct 2025US 2025/0304969 A1E-Therapeutics PLC
- Lactose And Human Milk Oligosaccharides (HMOS) Production In Cells9 Jan 2025US 2025/0011825 A1Agency for Science, Technology and Research
- Inhibitors of expression and/or function10 Oct 2024US 2024/0336922 A1E-Therapeutics PLC
- Sequential Fermentative Production Of Oligosaccharides11 Jul 2024US 2024/0229093 A1Chr. Hansen A/S
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.